Graham Michael Strub

Dr. Graham Michael Strub

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
RSRavi Sun
Ravi Sun
HHaihong Zhang
Haihong Zhang
Syed MehdiSyed Mehdi
Syed Mehdi
GRGresham Thomas Richter
Gresham Thomas Richter
HBHayden H. Bowman
Hayden H. Bowman
GSGraham Michael Strub
Graham Michael Strub

1 March 2021 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
HZHaihong Zhang
Haihong Zhang
TWTing Wei
Ting Wei
AJAdam Johnson
Adam Johnson
RSRavi Sun
Ravi Sun
GRGresham Richter
Gresham Richter
GSGraham Michael Strub
Graham Michael Strub

16 December 2025 in The FASEB Journal
Verified
Journal Article
Open access
RSRavi Sun
Ravi Sun
HZHaihong Zhang
Haihong Zhang
SMSyed J. Mehdi
Syed J. Mehdi
JBJordan K. Bowen
Jordan K. Bowen
ABAlexander K. Burnett
Alexander K. Burnett
GSGraham Michael Strub
Graham Michael Strub
Cystic lymphatic malformations (LMs) are congenital anomalies characterized by the formation of dilated lymphatic channels that can infiltrate adjacent structures and cause significant morbidity. Somatic activating single nucleotide variants in PIK3CA have been identified in the majority of these lesions, yet the precise mechanisms underlying the role of these variants in LM progression remain unclear. Here, we investigated the role of Angiopoietin‐2 (Ang2) downregulation downstream of pathogenic PIK3CA variants in the pathogenesis of LMs and delineated a novel inhibitory mechanism for autocrine Ang2 in the lymphatic vasculature. Transcriptomic profiling of patient‐derived LM endothelial cells (LMECs) with PIK3CA variants revealed Ang2 as one of the most significantly downregulated genes. Overexpression of ANG2 in LMECs and normal human dermal lymphatic endothelial cells significantly suppressed their proliferation and inhibited VEGFR3 expression. In contrast, non‐cell autonomous derived or exogenous ANG2 significantly promoted LMEC viability and increased AKT activity. Treatment of LMECs with the PI3K inhibitor alpelisib, but not the mTOR inhibitor sirolimus (rapamycin), rescued autocrine ANG2 expression and significantly downregulated VEGFR3. Alpelisib or sirolimus in combination with ANG2 overexpression significantly reduced LMEC viability compared to ANG2 overexpression or drug treatment alone. Finally, ANG2 overexpression in LMECs suppressed the LM phenotype in a murine xenograft model. Together, our findings suggest that targeting autocrine Ang2 signaling may be a viable option for suppressing pathological lymphangiogenesis.

5 October 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TWTing Wei
Ting Wei
GRGresham T. Richter
Gresham T. Richter
HZHaihong Zhang
Haihong Zhang
RSRavi W. Sun
Ravi W. Sun
CSConor H. Smith
Conor H. Smith
GSGraham Michael Strub
Graham Michael Strub
Extracranial arteriovenous malformations (AVMs) are characterized by anomalous arterial-to-venous connections, aberrant angiogenesis, local inflammation and hypoxia, and disorganized histological architecture; however, the precise molecular perturbations leading to this phenotype remain elusive. We hypothesized that extracranial AVM tissue would demonstrate deregulation of the TGF-β/BMP signaling pathway, which may serve as a potential target in the development of molecular-based therapies for AVMs. AVM tissue was harvested during resection from 10 patients with AVMs and compared to control tissue. Blood was collected from 14 AVM patients and 10 patients without AVMs as controls. Expression of TGF-β/BMP pathway components was analyzed using RT-PCR, western blotting, and immunohistochemistry. Circulating levels of TGF-β1 were analyzed by ELISA. Paired t tests were utilized to perform statistical analysis. The mRNA levels of TGF-β1, ALK1, Endoglin (ENG), Smad6, Smad7, and Smad8 were significantly elevated in AVM tissue when compared to controls. Protein levels of TGF-β1 and Smad3 were elevated in AVM tissue while protein levels of BMP-9, ALK1, Smad1, Smad6, and Smad8 were significantly decreased in AVMs. Immunohistochemistry demonstrated increased TGF-β1 in the perivascular cells of AVMs compared to normal controls, and circulating levels of TGF-β1 were significantly higher in AVM patients. Patients with AVMs demonstrate aberrant TGF-β/BMP expression in AVM tissue and blood compared to controls. Targeting aberrantly expressed components of the TGF-β/BMP pathway in extracranial AVMs may be a viable approach in the development of novel molecular therapies, and monitoring circulating TGF-β1 levels may be a useful indicator of treatment success.

27 December 2023 in The Laryngoscope
Verified
Journal Article
Closed access
AGA. Celeste Gibson
A. Celeste Gibson
MCMadison Coleman
Madison Coleman
HWHannah B. Wilkins
Hannah B. Wilkins
TEThejovathi Edala
Thejovathi Edala
SNSara Nowroozizadeh
Sara Nowroozizadeh
GSGraham Michael Strub
Graham Michael Strub

13 September 2022 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
CLChrystal O. Lau
Chrystal O. Lau
AJAdam B. Johnson
Adam B. Johnson
ANAbby R. Nolder
Abby R. Nolder
DKDeanne King
Deanne King
GSGraham Michael Strub
Graham Michael Strub
Objective Improve the quality and diversity of candidates invited for the Otolaryngology-Head and Neck Surgery residency match by reducing geographical and inter-rater bias with a novel geographic distribution algorithm. Methods Interview applicants were divided into geographic regions and assigned to reviewers. Each reviewer selected by force-ranking a pre-determined number of applicants to invite for interviews based on the percentage of applications received for each region. Our novel geographic distribution algorithm was then applied to maintain the geographic representation and underrepresented minority status of invited applicants to match the applicant pool. Results Analysis of previous interview selection methods demonstrated a statistically significant overrepresentation of local applicants invited for interviews. In 2022, 324 domestic applications were received for the otolaryngology match, which were divided into six geographic regions. There was no significant difference in USMLE scores between regions. The implementation of our distribution algorithm during applicant selection eliminated local overrepresentation in the invited pool of applicants and maintained the representation of underrepresented minority applicants. Following the match, reviewers indicated that implementation of the geographic distribution algorithm was simple and improved the quality and diversity of the group of interviewed applicants. Conclusion Traditional methods of scoring and inviting otolaryngology residency applicants can be confounded by regional and inter-rater biases. Employing a geographic distribution algorithm improves the quality and diversity of invited applicants, eliminates bias, and maintains the representation of underrepresented minority applicants.